人工涙液市場 : 2030年までの予測

Artificial Tears Forecast till 2030

Market Overview
The rising pervasiveness of dry eye infection and eye irritation, and the rising inclination for additive free items are driving market development.
The rising interest for additive free artificial tears inferable from the results of additives including eye disturbance, particularly for moderate or serious dry eyes is driving the artificial tears market. Moreover, the rising number of item dispatches by vital participants is expanding item separation and consequently driving market development. For example, In January 2022, Alcon (Switzerland) sent off Systane complete additive free oil eye drops in the European market. Similarly, in October 2019, Allergan, Inc. (Auxiliary of AbbVie, US) sent off the Invigorate Relieva grease eye drop product offering, an extension of the Revive portfolio. The product offering included Revive Relieva PF (additive free) multidose.
Moreover, expanding item dispatches for additive free items is driving the artificial tears market. Besides, propels in bundling plan and conveyance systems for additive free eye drops to forestall tainting are further driving the market for artificial tears market. Hence, expanding inclination for additive free items is driving the market development.

Market Segmentation
Based on type, the Artificial Tears Market is divided into segments such as cellulose, glycerin, propylene glycol, and polyethylene glycol. The market is separated into eye drops, ointments, and sprays based on the mechanism of delivery.
The dry eye condition, allergies, infections, and other conditions are categorized under the application sector of the artificial tears market. Hospital pharmacies, drug stores, retail pharmacies, and internet pharmacies are all part of the distribution system.

Regional Insights
The North America artificial tears market represented the largest market owing to the of the great commonness of dry eye sickness, the presence of market vital participants, and the developing interest for contact focal points in the region Dry eye illness is exceptionally far reaching in the US, influencing a huge level of the populace, especially those beyond 50 years old.
Europe artificial tears market represents the second-largest market owing to the great pervasiveness of ophthalmic issues, expanding utilization of cutting-edge eye drops, and a quickly flooding maturing populace. further, UK artificial tears market was credited to hold the biggest market share, and the France artificial tears market is supposed to quickest developing market in the European region.
The Asia-Pacific artificial tears market is supposed to develop at a fast rate during the review period. This is because of the solid likely persistent populace, rising consciousness of visual illnesses, and expanding medical services consumption in the Asia-Pacific region. Besides, China artificial tears market is supposed to hold the biggest market offer, and India artificial tears market is normal quickest developing market in the Asia-Pacific region.

Major Players
Key Companies in the worldwide Artificial Tears Market are Johnson and Johnson Vision Care (US), Allergan plc (Ireland), Alcon Plc (Switzerland), Bausch & Lomb Incorporated (Canada), Santen, Inc (Japan), URSAPHARM Arzneimittel GmbH (Germany), ROHTO Pharmaceutical CO., LTD (Japan), Similasan Corporation (US), Ocusoft (US), and Nicox (France).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF DRY EYE DISEASE AND EYE INFLAMMATION

4.2.2 RISING PREFERENCE FOR PRESERVATIVE-FREE PRODUCTS

4.3 RESTRAINTS

4.3.1 SIDE-EFFECTS AND ALLERGIC REACTIONS

4.4 OPPORTUNITIES

4.4.1 ADVANCEMENT IN DIAGNOSTICS FOR DRY EYE DISEASE

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE ARTIFICIAL TEARS MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON MANUFACTURERS

5.4 PRICING ANALYSIS

6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE

6.1 OVERVIEW

6.2 POLYETHYLENE GLYCOL

6.3 PROPYLENE GLYCOL

6.4 CELLULOSE

6.5 GLYCERIN

6.6 OTHERS

7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE

7.1 OVERVIEW

7.2 EYE DROPS

7.3 OINTMENTS

7.4 SPRAYS

8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 DRY EYE SYNDROME

8.3 ALLERGIES AND INFECTIONS

8.4 OTHERS

9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 HOSPITAL PHARMACIES

9.3 DRUG STORES

9.4 RETAIL PHARMACIES

9.5 ONLINE PHARMACIES

10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 UK

10.3.3 FRANCE

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.7.1 PRODUCT LAUNCH

11.7.2 COLLABORATION

11.7.3 AGREEMENT

11.7.4 ACQUISITION

11.7.5 PARTNERSHIP

11.8 MAJOR PLAYERS FINANCIAL MATRIX

11.8.1 SALES (USD BILLION), 2022

11.8.2 R&D (USD BILLION), 2022

12 COMPANY PROFILES

12.1 JOHNSON AND JOHNSON VISION CARE

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 ALLERGAN PLC

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 ALCON PLC

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 BAUSCH & LOMB INCORPORATED

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 SANTEN, INC.

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 URSAPHARM ARZNEIMITTEL GMBH

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 ROHTO PHARMACEUTICAL CO., LTD.

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 KEY STRATEGIES

12.8 SIMILASAN CORPORATION

12.8.1 COMPANY OVERVIEWS

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 KEY STRATEGIES

12.9 OCUSOFT

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

12.10 NICOX

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 4 GLOBAL ARTIFICIAL TEARS MARKET, FOR POLYETHYLENE GLYCOL, BY REGION, 2019–2030 (USD BILLION)

TABLE 5 GLOBAL ARTIFICIAL TEARS MARKET, FOR PROPYLENE GLYCOL, BY REGION, 2019–2030 (USD BILLION)

TABLE 6 GLOBAL ARTIFICIAL TEARS MARKET, FOR CELLULOSE, BY REGION, 2019–2030 (USD BILLION)

TABLE 7 GLOBAL ARTIFICIAL TEARS MARKET, FOR GLYCERIN, BY REGION, 2019–2030 (USD BILLION)

TABLE 8 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 10 GLOBAL ARTIFICIAL TEARS MARKET, FOR EYE DROPS, BY REGION, 2019–2030 (USD BILLION)

TABLE 11 GLOBAL ARTIFICIAL TEARS MARKET, FOR OINTMENTS, BY REGION, 2019–2030 (USD BILLION)

TABLE 12 GLOBAL ARTIFICIAL TEARS MARKET, FOR SPRAYS, BY REGION, 2019–2030 (USD BILLION)

TABLE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 14 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRY EYE SYNDROME, BY REGION, 2019–2030 (USD BILLION)

TABLE 15 GLOBAL ARTIFICIAL TEARS MARKET, FOR ALLERGIES AND INFECTIONS, BY REGION, 2019–2030 (USD BILLION)

TABLE 16 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 18 GLOBAL ARTIFICIAL TEARS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 19 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRUG STORES, BY REGION, 2019–2030 (USD BILLION)

TABLE 20 GLOBAL ARTIFICIAL TEARS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 21 GLOBAL ARTIFICIAL TEARS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 22 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2019–2030 (USD BILLION)

TABLE 23 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 24 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 25 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 26 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 27 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 28 US: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 29 US: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 30 US: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 31 US: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 32 CANADA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 33 CANADA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 34 CANADA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 35 CANADA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 36 EUROPE: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 37 EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 38 EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 39 EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 40 EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 41 GERMANY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 42 GERMANY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 43 GERMANY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 44 GERMANY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 45 UK: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 46 UK: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 47 UK: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 48 UK: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 49 FRANCE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 50 FRANCE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 51 FRANCE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 52 FRANCE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 53 ITALY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 54 ITALY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 55 ITALY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 56 ITALY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 57 SPAIN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 58 SPAIN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 59 SPAIN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 60 SPAIN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 61 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 62 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 63 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 64 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 65 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 66 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 67 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 68 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 69 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 70 JAPAN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 71 JAPAN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 72 JAPAN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 73 JAPAN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 74 CHINA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 75 CHINA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 76 CHINA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 77 CHINA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 78 INDIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 79 INDIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 80 INDIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 81 INDIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 82 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 83 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 84 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 85 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 86 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 87 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 88 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 89 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 90 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 91 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 92 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 93 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 94 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 95 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 96 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 97 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 98 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 99 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 100 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 101 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 102 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 103 AFRICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 104 AFRICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 105 AFRICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 106 AFRICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 107 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 108 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 109 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 110 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 111 MAJOR PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET

TABLE 2 MOST ACTIVE PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET

TABLE 3 PRODUCT LAUNCH

TABLE 4 COLLABORATION

TABLE 5 AGREEMENT

TABLE 6 ACQUISITION

TABLE 7 PARTNERSHIP

TABLE 8 JOHNSON AND JOHNSON VISION: PRODUCTS OFFERED

TABLE 9 ALLERGAN PLC: PRODUCTS OFFERED

TABLE 10 ALLERGAN PLC: KEY DEVELOPMENTS

TABLE 11 ALCON PLC: PRODUCTS OFFERED

TABLE 12 ALCON PLC: KEY DEVELOPMENTS

TABLE 13 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED

TABLE 14 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS

TABLE 15 SANTEN PHARMACEUTICALS INC.: PRODUCTS OFFERED

TABLE 16 URSAPHARM ARZNEIMITTEL GMBH: PRODUCTS OFFERED

TABLE 17 URSAPHARM ARZNEIMITTEL GMBH: KEY DEVELOPMENTS

TABLE 18 ROHTO PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED

TABLE 19 ROHTO PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS

TABLE 20 SIMILASAN CORPORATION: PRODUCTS OFFERED

TABLE 21 OCUSOFT: PRODUCTS OFFERED

TABLE 22 OCUSOFT: KEY DEVELOPMENTS

TABLE 23 NICOX: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL ARTIFICIAL TEARS MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: PROTEIN ENGINEERING MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ARTIFICIAL TEARS MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: ARTIFICIAL TEARS MARKET

FIGURE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2022 & 2030 (USD BILLION)

FIGURE 10 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY TYPE (%), 2022

FIGURE 11 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2022 & 2030 (USD BILLION)

FIGURE 12 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DELIVERY MODE (%), 2022

FIGURE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)

FIGURE 14 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY APPLICATION (%), 2022

FIGURE 15 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (USD BILLION)

FIGURE 16 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DISTRIBUTION CHANNEL (%), 2022

FIGURE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2022 & 2030 (USD BILLION)

FIGURE 18 GLOBAL ARTIFICIAL TEARS MARKET SHARE (%), BY REGION, 2022

FIGURE 19 NORTH AMERICA: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 20 EUROPE ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 21 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 22 REST OF THE WORLD: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET

FIGURE 25 GLOBAL ARTIFICIAL TEARS MARKET: COMPETITIVE LANDSCAPE

FIGURE 26 SALES, 2021

FIGURE 27 R&D, 2021

FIGURE 28 JOHNSON AND JOHNSON VISION: SWOT ANALYSIS

FIGURE 29 ALLERGAN PLC: SWOT ANALYSIS

FIGURE 30 ALCON PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ALCON PLC: SWOT ANALYSIS

FIGURE 32 BAUSCH & LOMB INCORPORATED: SWOT ANALYSIS

FIGURE 33 SANTEN PHARMACEUTICALS INC.: FINANCIAL OVERVIEW

FIGURE 34 SANTEN PHARMACEUTICALS INC.: SWOT ANALYSIS

FIGURE 35 NICOX: FINANCIAL OVERVIEW SNAPSHOT